79.1%) was significantly different (90.0% [vein group] vs 62.9% [HePTFE group]; P = .021). Survival was similar between the groups (47.3% vs 42.9%; P = .582) as well as MALE free survival (69.4% vs 55.0%; P = .348).Conclusion: Bypasses to the below knee popliteal artery show good results in patients with CLI unsuitable for endovascular therapy. Vein is still the first line graft material.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.